Plus Therapeutics, Inc. (PSTV) NASDAQ
6.43
+0.6(+10.29%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.43
+0.6(+10.29%)
Currency In USD
| Market Cap | 39.87M |
| Enterprise Value | 31.93M |
| P/E Ratio | -3.58 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 3 |
| Price/Book Ratio | 3.57 |
| Enterprise/Revenue | 2.56 |
| Enterprise/EBITDA | -1.58 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -2.3 |
| Operating Margin | -3.64 |
| Return On Assets | -0.6 |
| Return On Equity | -1.98 |
| Revenue | 5.21M |
| Revenue/Share | 0.78 |
| Gross Profit | 4.77M |
| EBITDA | -14.85M |
| Net Income | -22.39M |
| Diluted EPS | -7.19 |
| Total Cash | 3.02M |
| Total Cash/Share | 0.45 |
| Total Debt | 725,000 |
| Total Debt/Equity | 0.06 |
| Current Ratio | 2.27 |
| Book Value Per Share | 1.8 |
| 52-Week Change | -19.02 |
| 52-Week High | 23.5 |
| 52-Week Low | 2.9 |
| Moving Average 50 Days | 5.8 |
| Moving Average 200 Days | 10.85 |
| Average Volume | 324,899 |
| Shares Outstanding | 2.42M |
| % Held by Institutions | 7.41 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | April 02, 2026 |